InspireMD Inc Stock Nyse
Equities
US45779A3095
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
||
- USD | - |
03-06 | Transcript : InspireMD, Inc., Q4 2023 Earnings Call, Mar 06, 2024 | |
03-06 | Earnings Flash (NSPR) INSPIREMD Posts Q4 Revenue $1.8M | MT |
Sales 2024 * | 7.09M 9.7M | Sales 2025 * | 14.65M 20.03M | Capitalization | 56.22M 76.89M |
---|---|---|---|---|---|
Net income 2024 * | - | Net income 2025 * | - | EV / Sales 2024 * | 7.92 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 3.84 x |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 81.51% |
Latest transcript on InspireMD Inc
Managers | Title | Age | Since |
---|---|---|---|
Marvin Slosman
CEO | Chief Executive Officer | 60 | 19-12-31 |
Craig Shore
DFI | Director of Finance/CFO | 62 | 11-03-30 |
Juan Rigla
CTO | Chief Tech/Sci/R&D Officer | - | 13-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Gary Roubin
BRD | Director/Board Member | 75 | 20-10-12 |
Marvin Slosman
CEO | Chief Executive Officer | 60 | 19-12-31 |
Thomas Kester
BRD | Director/Board Member | 77 | 16-09-05 |
1st Jan change | Capi. | |
---|---|---|
-4.82% | 182B | |
+1.38% | 111B | |
-2.82% | 68.48B | |
+0.69% | 49.69B | |
+8.54% | 44.46B | |
+2.33% | 40.67B | |
+20.50% | 31.22B | |
+1.72% | 26.09B | |
+15.30% | 25.32B |